Author: Akinsanya Jonathan Diggory Paul Heitz Elizabeth Jones Valerie
Publisher: Royal College Of Physicians
ISSN: 1470-2118
Source: Clinical Medicine, Vol.9, Iss.3, 2009-06, pp. : 239-241
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
When offering treatment to a patient with capacity they should be informed of the risks and benefits of therapy and consent should be obtained. For patients without capacity, treatment is given in their ‘best interests’. Achieving and assessing capacity to consent for treatment in the presence of acute illness can be difficult and especially so in patients suffering with acute stroke. This article presents patients’ and doctors’ perspectives on assessing capacity to consent to thrombolytic therapy for stroke.
Related content
Thrombolysis for Acute Ischemic Stroke
Current Topics in Medicinal Chemistry, Vol. 9, Iss. 14, 2009-10 ,pp. :
Thrombolysis in Acute Ischaemic Stroke: A Guide to Patient Selection
CNS Drugs, Vol. 19, Iss. 6, 2005-01 ,pp. :